Showing results (51-60 of 65) with videos related to
Sort By:
Pageof 7
British Journal of Haematology|February 10, 2023
Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experienceBeata Ostrowska, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, et al.Blood|December 21, 2012
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphomaItziar Salaverria, Cristina Royo, Alejandra Carvajal-Cuenca, et al.British Journal of Haematology|December 4, 2019
First-line R-CVP versus R-CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4Jan Walewski, Ewa Paszkiewicz-Kozik, Wojciech Michalski, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 22, 2023
A New Hierarchy of Research Evidence for Tumor Pathology: A Delphi Study to Define Levels of Evidence in Tumor PathologyRichard Colling, Iciar Indave, Javier Del Aguila, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma NetworkEva Hoster, Andreas Rosenwald, Françoise Berger, et al.British Journal of Haematology|April 1, 2022
Ofatumumab with iphosphamide, etoposide and cytarabine for patients with transplantation-ineligible relapsed and refractory diffuse large B-cell lymphomaEwa Paszkiewicz-Kozik, Wojciech Michalski, Michał Taszner, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 19, 2024
Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type GroupRichard Colling, Iciar Indave, Javier Del Aguilla, et al.Journal of Hematopathology|August 12, 2009
Ki-67 as a prognostic marker in mantle cell lymphoma-consensus guidelines of the pathology panel of the European MCL NetworkWolfram Klapper, Eva Hoster, Olaf Determann, et al.European Journal of Cancer (Oxford, England : 1990)|May 15, 2026
The long-term efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in the treatment of primary central nervous system lymphoma: A real-world report from the Polish Lymphoma Research GroupBeata Ostrowska, Katarzyna Domanska-Czyz, Agnieszka Giza, et al.Cell Death & Disease|December 26, 2025
PIM kinase inhibition attenuates pro-tumoral and immunosuppressive functions of macrophages in classic Hodgkin lymphomaMaciej Szydłowski, Ewa Kurtz, Filip Garbicz, et al.Pageof 7